Clinical Trial Update: Empirical Versus Preemptive Antifungal Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing empirical versus preemptive antifungal therapy in patients with fungal infection and leukemia/myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infection
• Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Fungal Infection, Leukemia | Phase 3 | Status: COMPLETED